Pharma & Healthcare
Global Anti-aging Drugs Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Aug 11, 25
- ID: 437744
- Pages: 112
- Figures: 119
- Views: 3
The global Anti-aging Drugs market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
AbbVie
Galderma
LG Life Sciences
Merz
Medytox
Hugel
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Bohus BioTech
Caregen
Ipsen
LIBP
US World Meds
Daewoong
JETEMA
By Type: (Dominant Segment vs High-Margin Innovation)
Dermal Fillers
Botulinum Toxin
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospital
Beauty Parlor
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., AbbVie in Europe)
- Emerging Product Trends: Dermal Fillers adoption vs. Botulinum Toxin premiumization
- Demand-Side Dynamics: Hospital growth in China vs. Beauty Parlor potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
South Korea
Taiwan (China)
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Anti-aging Drugs market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Botulinum Toxin in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Beauty Parlor in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Dermal Fillers dominance in Europe vs. Botulinum Toxin demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Market Segmentation
By Company:
AbbVie
Galderma
LG Life Sciences
Merz
Medytox
Hugel
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Bohus BioTech
Caregen
Ipsen
LIBP
US World Meds
Daewoong
JETEMA
By Type: (Dominant Segment vs High-Margin Innovation)
Dermal Fillers
Botulinum Toxin
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospital
Beauty Parlor
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., AbbVie in Europe)
- Emerging Product Trends: Dermal Fillers adoption vs. Botulinum Toxin premiumization
- Demand-Side Dynamics: Hospital growth in China vs. Beauty Parlor potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
South Korea
Taiwan (China)
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Anti-aging Drugs market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Botulinum Toxin in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Beauty Parlor in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Dermal Fillers dominance in Europe vs. Botulinum Toxin demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Anti-aging Drugs Product Scope
1.2 Anti-aging Drugs by Type
1.2.1 Global Anti-aging Drugs Sales by Type (2020 & 2024 & 2031)
1.2.2 Dermal Fillers
1.2.3 Botulinum Toxin
1.2.4 Others
1.3 Anti-aging Drugs by Application
1.3.1 Global Anti-aging Drugs Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospital
1.3.3 Beauty Parlor
1.3.4 Others
1.4 Global Anti-aging Drugs Market Estimates and Forecasts (2020-2031)
1.4.1 Global Anti-aging Drugs Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Anti-aging Drugs Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Anti-aging Drugs Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Anti-aging Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Anti-aging Drugs Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Anti-aging Drugs Sales Market Share by Region (2020-2025)
2.2.2 Global Anti-aging Drugs Revenue Market Share by Region (2020-2025)
2.3 Global Anti-aging Drugs Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Anti-aging Drugs Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Anti-aging Drugs Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Anti-aging Drugs Market Size and Prospective (2020-2031)
2.4.2 Europe Anti-aging Drugs Market Size and Prospective (2020-2031)
2.4.3 China Anti-aging Drugs Market Size and Prospective (2020-2031)
2.4.4 South Korea Anti-aging Drugs Market Size and Prospective (2020-2031)
2.4.5 Taiwan (China) Anti-aging Drugs Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Anti-aging Drugs Historic Market Review by Type (2020-2025)
3.1.1 Global Anti-aging Drugs Sales by Type (2020-2025)
3.1.2 Global Anti-aging Drugs Revenue by Type (2020-2025)
3.1.3 Global Anti-aging Drugs Price by Type (2020-2025)
3.2 Global Anti-aging Drugs Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Anti-aging Drugs Sales Forecast by Type (2026-2031)
3.2.2 Global Anti-aging Drugs Revenue Forecast by Type (2026-2031)
3.2.3 Global Anti-aging Drugs Price Forecast by Type (2026-2031)
3.3 Different Types Anti-aging Drugs Representative Players
4 Global Market Size by Application
4.1 Global Anti-aging Drugs Historic Market Review by Application (2020-2025)
4.1.1 Global Anti-aging Drugs Sales by Application (2020-2025)
4.1.2 Global Anti-aging Drugs Revenue by Application (2020-2025)
4.1.3 Global Anti-aging Drugs Price by Application (2020-2025)
4.2 Global Anti-aging Drugs Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Anti-aging Drugs Sales Forecast by Application (2026-2031)
4.2.2 Global Anti-aging Drugs Revenue Forecast by Application (2026-2031)
4.2.3 Global Anti-aging Drugs Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Anti-aging Drugs Application
5 Competition Landscape by Players
5.1 Global Anti-aging Drugs Sales by Players (2020-2025)
5.2 Global Top Anti-aging Drugs Players by Revenue (2020-2025)
5.3 Global Anti-aging Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-aging Drugs as of 2024)
5.4 Global Anti-aging Drugs Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Anti-aging Drugs, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Anti-aging Drugs, Product Type & Application
5.7 Global Key Manufacturers of Anti-aging Drugs, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Anti-aging Drugs Sales by Company
6.1.1.1 North America Anti-aging Drugs Sales by Company (2020-2025)
6.1.1.2 North America Anti-aging Drugs Revenue by Company (2020-2025)
6.1.2 North America Anti-aging Drugs Sales Breakdown by Type (2020-2025)
6.1.3 North America Anti-aging Drugs Sales Breakdown by Application (2020-2025)
6.1.4 North America Anti-aging Drugs Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Anti-aging Drugs Sales by Company
6.2.1.1 Europe Anti-aging Drugs Sales by Company (2020-2025)
6.2.1.2 Europe Anti-aging Drugs Revenue by Company (2020-2025)
6.2.2 Europe Anti-aging Drugs Sales Breakdown by Type (2020-2025)
6.2.3 Europe Anti-aging Drugs Sales Breakdown by Application (2020-2025)
6.2.4 Europe Anti-aging Drugs Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Anti-aging Drugs Sales by Company
6.3.1.1 China Anti-aging Drugs Sales by Company (2020-2025)
6.3.1.2 China Anti-aging Drugs Revenue by Company (2020-2025)
6.3.2 China Anti-aging Drugs Sales Breakdown by Type (2020-2025)
6.3.3 China Anti-aging Drugs Sales Breakdown by Application (2020-2025)
6.3.4 China Anti-aging Drugs Major Customer
6.3.5 China Market Trend and Opportunities
6.4 South Korea Market: Players, Segments, Downstream and Major Customers
6.4.1 South Korea Anti-aging Drugs Sales by Company
6.4.1.1 South Korea Anti-aging Drugs Sales by Company (2020-2025)
6.4.1.2 South Korea Anti-aging Drugs Revenue by Company (2020-2025)
6.4.2 South Korea Anti-aging Drugs Sales Breakdown by Type (2020-2025)
6.4.3 South Korea Anti-aging Drugs Sales Breakdown by Application (2020-2025)
6.4.4 South Korea Anti-aging Drugs Major Customer
6.4.5 South Korea Market Trend and Opportunities
6.5 Taiwan (China) Market: Players, Segments, Downstream and Major Customers
6.5.1 Taiwan (China) Anti-aging Drugs Sales by Company
6.5.1.1 Taiwan (China) Anti-aging Drugs Sales by Company (2020-2025)
6.5.1.2 Taiwan (China) Anti-aging Drugs Revenue by Company (2020-2025)
6.5.2 Taiwan (China) Anti-aging Drugs Sales Breakdown by Type (2020-2025)
6.5.3 Taiwan (China) Anti-aging Drugs Sales Breakdown by Application (2020-2025)
6.5.4 Taiwan (China) Anti-aging Drugs Major Customer
6.5.5 Taiwan (China) Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 AbbVie
7.1.1 AbbVie Company Information
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.1.4 AbbVie Anti-aging Drugs Products Offered
7.1.5 AbbVie Recent Development
7.2 Galderma
7.2.1 Galderma Company Information
7.2.2 Galderma Business Overview
7.2.3 Galderma Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Galderma Anti-aging Drugs Products Offered
7.2.5 Galderma Recent Development
7.3 LG Life Sciences
7.3.1 LG Life Sciences Company Information
7.3.2 LG Life Sciences Business Overview
7.3.3 LG Life Sciences Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.3.4 LG Life Sciences Anti-aging Drugs Products Offered
7.3.5 LG Life Sciences Recent Development
7.4 Merz
7.4.1 Merz Company Information
7.4.2 Merz Business Overview
7.4.3 Merz Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Merz Anti-aging Drugs Products Offered
7.4.5 Merz Recent Development
7.5 Medytox
7.5.1 Medytox Company Information
7.5.2 Medytox Business Overview
7.5.3 Medytox Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Medytox Anti-aging Drugs Products Offered
7.5.5 Medytox Recent Development
7.6 Hugel
7.6.1 Hugel Company Information
7.6.2 Hugel Business Overview
7.6.3 Hugel Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Hugel Anti-aging Drugs Products Offered
7.6.5 Hugel Recent Development
7.7 Croma-Pharma
7.7.1 Croma-Pharma Company Information
7.7.2 Croma-Pharma Business Overview
7.7.3 Croma-Pharma Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Croma-Pharma Anti-aging Drugs Products Offered
7.7.5 Croma-Pharma Recent Development
7.8 Beijing IMEIK
7.8.1 Beijing IMEIK Company Information
7.8.2 Beijing IMEIK Business Overview
7.8.3 Beijing IMEIK Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Beijing IMEIK Anti-aging Drugs Products Offered
7.8.5 Beijing IMEIK Recent Development
7.9 Bloomage Bio
7.9.1 Bloomage Bio Company Information
7.9.2 Bloomage Bio Business Overview
7.9.3 Bloomage Bio Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Bloomage Bio Anti-aging Drugs Products Offered
7.9.5 Bloomage Bio Recent Development
7.10 Elravie (Humedix)
7.10.1 Elravie (Humedix) Company Information
7.10.2 Elravie (Humedix) Business Overview
7.10.3 Elravie (Humedix) Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Elravie (Humedix) Anti-aging Drugs Products Offered
7.10.5 Elravie (Humedix) Recent Development
7.11 Cleviel (Pharma Research Products)
7.11.1 Cleviel (Pharma Research Products) Company Information
7.11.2 Cleviel (Pharma Research Products) Business Overview
7.11.3 Cleviel (Pharma Research Products) Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Cleviel (Pharma Research Products) Anti-aging Drugs Products Offered
7.11.5 Cleviel (Pharma Research Products) Recent Development
7.12 Haohai Biological
7.12.1 Haohai Biological Company Information
7.12.2 Haohai Biological Business Overview
7.12.3 Haohai Biological Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Haohai Biological Anti-aging Drugs Products Offered
7.12.5 Haohai Biological Recent Development
7.13 Teoxane
7.13.1 Teoxane Company Information
7.13.2 Teoxane Business Overview
7.13.3 Teoxane Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Teoxane Anti-aging Drugs Products Offered
7.13.5 Teoxane Recent Development
7.14 Sinclair
7.14.1 Sinclair Company Information
7.14.2 Sinclair Business Overview
7.14.3 Sinclair Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Sinclair Anti-aging Drugs Products Offered
7.14.5 Sinclair Recent Development
7.15 Suneva Medical
7.15.1 Suneva Medical Company Information
7.15.2 Suneva Medical Business Overview
7.15.3 Suneva Medical Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Suneva Medical Anti-aging Drugs Products Offered
7.15.5 Suneva Medical Recent Development
7.16 CG Bio
7.16.1 CG Bio Company Information
7.16.2 CG Bio Business Overview
7.16.3 CG Bio Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.16.4 CG Bio Anti-aging Drugs Products Offered
7.16.5 CG Bio Recent Development
7.17 SciVision Biotech
7.17.1 SciVision Biotech Company Information
7.17.2 SciVision Biotech Business Overview
7.17.3 SciVision Biotech Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.17.4 SciVision Biotech Anti-aging Drugs Products Offered
7.17.5 SciVision Biotech Recent Development
7.18 Prollenium
7.18.1 Prollenium Company Information
7.18.2 Prollenium Business Overview
7.18.3 Prollenium Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Prollenium Anti-aging Drugs Products Offered
7.18.5 Prollenium Recent Development
7.19 Bohus BioTech
7.19.1 Bohus BioTech Company Information
7.19.2 Bohus BioTech Business Overview
7.19.3 Bohus BioTech Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.19.4 Bohus BioTech Anti-aging Drugs Products Offered
7.19.5 Bohus BioTech Recent Development
7.20 Caregen
7.20.1 Caregen Company Information
7.20.2 Caregen Business Overview
7.20.3 Caregen Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.20.4 Caregen Anti-aging Drugs Products Offered
7.20.5 Caregen Recent Development
7.21 Ipsen
7.21.1 Ipsen Company Information
7.21.2 Ipsen Business Overview
7.21.3 Ipsen Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.21.4 Ipsen Anti-aging Drugs Products Offered
7.21.5 Ipsen Recent Development
7.22 LIBP
7.22.1 LIBP Company Information
7.22.2 LIBP Business Overview
7.22.3 LIBP Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.22.4 LIBP Anti-aging Drugs Products Offered
7.22.5 LIBP Recent Development
7.23 US World Meds
7.23.1 US World Meds Company Information
7.23.2 US World Meds Business Overview
7.23.3 US World Meds Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.23.4 US World Meds Anti-aging Drugs Products Offered
7.23.5 US World Meds Recent Development
7.24 Daewoong
7.24.1 Daewoong Company Information
7.24.2 Daewoong Business Overview
7.24.3 Daewoong Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.24.4 Daewoong Anti-aging Drugs Products Offered
7.24.5 Daewoong Recent Development
7.25 JETEMA
7.25.1 JETEMA Company Information
7.25.2 JETEMA Business Overview
7.25.3 JETEMA Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.25.4 JETEMA Anti-aging Drugs Products Offered
7.25.5 JETEMA Recent Development
8 Anti-aging Drugs Manufacturing Cost Analysis
8.1 Anti-aging Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Anti-aging Drugs
8.4 Anti-aging Drugs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Anti-aging Drugs Distributors List
9.3 Anti-aging Drugs Customers
10 Anti-aging Drugs Market Dynamics
10.1 Anti-aging Drugs Industry Trends
10.2 Anti-aging Drugs Market Drivers
10.3 Anti-aging Drugs Market Challenges
10.4 Anti-aging Drugs Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Anti-aging Drugs Product Scope
1.2 Anti-aging Drugs by Type
1.2.1 Global Anti-aging Drugs Sales by Type (2020 & 2024 & 2031)
1.2.2 Dermal Fillers
1.2.3 Botulinum Toxin
1.2.4 Others
1.3 Anti-aging Drugs by Application
1.3.1 Global Anti-aging Drugs Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospital
1.3.3 Beauty Parlor
1.3.4 Others
1.4 Global Anti-aging Drugs Market Estimates and Forecasts (2020-2031)
1.4.1 Global Anti-aging Drugs Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Anti-aging Drugs Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Anti-aging Drugs Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Anti-aging Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Anti-aging Drugs Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Anti-aging Drugs Sales Market Share by Region (2020-2025)
2.2.2 Global Anti-aging Drugs Revenue Market Share by Region (2020-2025)
2.3 Global Anti-aging Drugs Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Anti-aging Drugs Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Anti-aging Drugs Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Anti-aging Drugs Market Size and Prospective (2020-2031)
2.4.2 Europe Anti-aging Drugs Market Size and Prospective (2020-2031)
2.4.3 China Anti-aging Drugs Market Size and Prospective (2020-2031)
2.4.4 South Korea Anti-aging Drugs Market Size and Prospective (2020-2031)
2.4.5 Taiwan (China) Anti-aging Drugs Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Anti-aging Drugs Historic Market Review by Type (2020-2025)
3.1.1 Global Anti-aging Drugs Sales by Type (2020-2025)
3.1.2 Global Anti-aging Drugs Revenue by Type (2020-2025)
3.1.3 Global Anti-aging Drugs Price by Type (2020-2025)
3.2 Global Anti-aging Drugs Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Anti-aging Drugs Sales Forecast by Type (2026-2031)
3.2.2 Global Anti-aging Drugs Revenue Forecast by Type (2026-2031)
3.2.3 Global Anti-aging Drugs Price Forecast by Type (2026-2031)
3.3 Different Types Anti-aging Drugs Representative Players
4 Global Market Size by Application
4.1 Global Anti-aging Drugs Historic Market Review by Application (2020-2025)
4.1.1 Global Anti-aging Drugs Sales by Application (2020-2025)
4.1.2 Global Anti-aging Drugs Revenue by Application (2020-2025)
4.1.3 Global Anti-aging Drugs Price by Application (2020-2025)
4.2 Global Anti-aging Drugs Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Anti-aging Drugs Sales Forecast by Application (2026-2031)
4.2.2 Global Anti-aging Drugs Revenue Forecast by Application (2026-2031)
4.2.3 Global Anti-aging Drugs Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Anti-aging Drugs Application
5 Competition Landscape by Players
5.1 Global Anti-aging Drugs Sales by Players (2020-2025)
5.2 Global Top Anti-aging Drugs Players by Revenue (2020-2025)
5.3 Global Anti-aging Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-aging Drugs as of 2024)
5.4 Global Anti-aging Drugs Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Anti-aging Drugs, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Anti-aging Drugs, Product Type & Application
5.7 Global Key Manufacturers of Anti-aging Drugs, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Anti-aging Drugs Sales by Company
6.1.1.1 North America Anti-aging Drugs Sales by Company (2020-2025)
6.1.1.2 North America Anti-aging Drugs Revenue by Company (2020-2025)
6.1.2 North America Anti-aging Drugs Sales Breakdown by Type (2020-2025)
6.1.3 North America Anti-aging Drugs Sales Breakdown by Application (2020-2025)
6.1.4 North America Anti-aging Drugs Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Anti-aging Drugs Sales by Company
6.2.1.1 Europe Anti-aging Drugs Sales by Company (2020-2025)
6.2.1.2 Europe Anti-aging Drugs Revenue by Company (2020-2025)
6.2.2 Europe Anti-aging Drugs Sales Breakdown by Type (2020-2025)
6.2.3 Europe Anti-aging Drugs Sales Breakdown by Application (2020-2025)
6.2.4 Europe Anti-aging Drugs Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Anti-aging Drugs Sales by Company
6.3.1.1 China Anti-aging Drugs Sales by Company (2020-2025)
6.3.1.2 China Anti-aging Drugs Revenue by Company (2020-2025)
6.3.2 China Anti-aging Drugs Sales Breakdown by Type (2020-2025)
6.3.3 China Anti-aging Drugs Sales Breakdown by Application (2020-2025)
6.3.4 China Anti-aging Drugs Major Customer
6.3.5 China Market Trend and Opportunities
6.4 South Korea Market: Players, Segments, Downstream and Major Customers
6.4.1 South Korea Anti-aging Drugs Sales by Company
6.4.1.1 South Korea Anti-aging Drugs Sales by Company (2020-2025)
6.4.1.2 South Korea Anti-aging Drugs Revenue by Company (2020-2025)
6.4.2 South Korea Anti-aging Drugs Sales Breakdown by Type (2020-2025)
6.4.3 South Korea Anti-aging Drugs Sales Breakdown by Application (2020-2025)
6.4.4 South Korea Anti-aging Drugs Major Customer
6.4.5 South Korea Market Trend and Opportunities
6.5 Taiwan (China) Market: Players, Segments, Downstream and Major Customers
6.5.1 Taiwan (China) Anti-aging Drugs Sales by Company
6.5.1.1 Taiwan (China) Anti-aging Drugs Sales by Company (2020-2025)
6.5.1.2 Taiwan (China) Anti-aging Drugs Revenue by Company (2020-2025)
6.5.2 Taiwan (China) Anti-aging Drugs Sales Breakdown by Type (2020-2025)
6.5.3 Taiwan (China) Anti-aging Drugs Sales Breakdown by Application (2020-2025)
6.5.4 Taiwan (China) Anti-aging Drugs Major Customer
6.5.5 Taiwan (China) Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 AbbVie
7.1.1 AbbVie Company Information
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.1.4 AbbVie Anti-aging Drugs Products Offered
7.1.5 AbbVie Recent Development
7.2 Galderma
7.2.1 Galderma Company Information
7.2.2 Galderma Business Overview
7.2.3 Galderma Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Galderma Anti-aging Drugs Products Offered
7.2.5 Galderma Recent Development
7.3 LG Life Sciences
7.3.1 LG Life Sciences Company Information
7.3.2 LG Life Sciences Business Overview
7.3.3 LG Life Sciences Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.3.4 LG Life Sciences Anti-aging Drugs Products Offered
7.3.5 LG Life Sciences Recent Development
7.4 Merz
7.4.1 Merz Company Information
7.4.2 Merz Business Overview
7.4.3 Merz Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Merz Anti-aging Drugs Products Offered
7.4.5 Merz Recent Development
7.5 Medytox
7.5.1 Medytox Company Information
7.5.2 Medytox Business Overview
7.5.3 Medytox Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Medytox Anti-aging Drugs Products Offered
7.5.5 Medytox Recent Development
7.6 Hugel
7.6.1 Hugel Company Information
7.6.2 Hugel Business Overview
7.6.3 Hugel Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Hugel Anti-aging Drugs Products Offered
7.6.5 Hugel Recent Development
7.7 Croma-Pharma
7.7.1 Croma-Pharma Company Information
7.7.2 Croma-Pharma Business Overview
7.7.3 Croma-Pharma Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Croma-Pharma Anti-aging Drugs Products Offered
7.7.5 Croma-Pharma Recent Development
7.8 Beijing IMEIK
7.8.1 Beijing IMEIK Company Information
7.8.2 Beijing IMEIK Business Overview
7.8.3 Beijing IMEIK Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Beijing IMEIK Anti-aging Drugs Products Offered
7.8.5 Beijing IMEIK Recent Development
7.9 Bloomage Bio
7.9.1 Bloomage Bio Company Information
7.9.2 Bloomage Bio Business Overview
7.9.3 Bloomage Bio Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Bloomage Bio Anti-aging Drugs Products Offered
7.9.5 Bloomage Bio Recent Development
7.10 Elravie (Humedix)
7.10.1 Elravie (Humedix) Company Information
7.10.2 Elravie (Humedix) Business Overview
7.10.3 Elravie (Humedix) Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Elravie (Humedix) Anti-aging Drugs Products Offered
7.10.5 Elravie (Humedix) Recent Development
7.11 Cleviel (Pharma Research Products)
7.11.1 Cleviel (Pharma Research Products) Company Information
7.11.2 Cleviel (Pharma Research Products) Business Overview
7.11.3 Cleviel (Pharma Research Products) Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Cleviel (Pharma Research Products) Anti-aging Drugs Products Offered
7.11.5 Cleviel (Pharma Research Products) Recent Development
7.12 Haohai Biological
7.12.1 Haohai Biological Company Information
7.12.2 Haohai Biological Business Overview
7.12.3 Haohai Biological Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Haohai Biological Anti-aging Drugs Products Offered
7.12.5 Haohai Biological Recent Development
7.13 Teoxane
7.13.1 Teoxane Company Information
7.13.2 Teoxane Business Overview
7.13.3 Teoxane Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Teoxane Anti-aging Drugs Products Offered
7.13.5 Teoxane Recent Development
7.14 Sinclair
7.14.1 Sinclair Company Information
7.14.2 Sinclair Business Overview
7.14.3 Sinclair Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Sinclair Anti-aging Drugs Products Offered
7.14.5 Sinclair Recent Development
7.15 Suneva Medical
7.15.1 Suneva Medical Company Information
7.15.2 Suneva Medical Business Overview
7.15.3 Suneva Medical Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Suneva Medical Anti-aging Drugs Products Offered
7.15.5 Suneva Medical Recent Development
7.16 CG Bio
7.16.1 CG Bio Company Information
7.16.2 CG Bio Business Overview
7.16.3 CG Bio Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.16.4 CG Bio Anti-aging Drugs Products Offered
7.16.5 CG Bio Recent Development
7.17 SciVision Biotech
7.17.1 SciVision Biotech Company Information
7.17.2 SciVision Biotech Business Overview
7.17.3 SciVision Biotech Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.17.4 SciVision Biotech Anti-aging Drugs Products Offered
7.17.5 SciVision Biotech Recent Development
7.18 Prollenium
7.18.1 Prollenium Company Information
7.18.2 Prollenium Business Overview
7.18.3 Prollenium Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Prollenium Anti-aging Drugs Products Offered
7.18.5 Prollenium Recent Development
7.19 Bohus BioTech
7.19.1 Bohus BioTech Company Information
7.19.2 Bohus BioTech Business Overview
7.19.3 Bohus BioTech Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.19.4 Bohus BioTech Anti-aging Drugs Products Offered
7.19.5 Bohus BioTech Recent Development
7.20 Caregen
7.20.1 Caregen Company Information
7.20.2 Caregen Business Overview
7.20.3 Caregen Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.20.4 Caregen Anti-aging Drugs Products Offered
7.20.5 Caregen Recent Development
7.21 Ipsen
7.21.1 Ipsen Company Information
7.21.2 Ipsen Business Overview
7.21.3 Ipsen Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.21.4 Ipsen Anti-aging Drugs Products Offered
7.21.5 Ipsen Recent Development
7.22 LIBP
7.22.1 LIBP Company Information
7.22.2 LIBP Business Overview
7.22.3 LIBP Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.22.4 LIBP Anti-aging Drugs Products Offered
7.22.5 LIBP Recent Development
7.23 US World Meds
7.23.1 US World Meds Company Information
7.23.2 US World Meds Business Overview
7.23.3 US World Meds Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.23.4 US World Meds Anti-aging Drugs Products Offered
7.23.5 US World Meds Recent Development
7.24 Daewoong
7.24.1 Daewoong Company Information
7.24.2 Daewoong Business Overview
7.24.3 Daewoong Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.24.4 Daewoong Anti-aging Drugs Products Offered
7.24.5 Daewoong Recent Development
7.25 JETEMA
7.25.1 JETEMA Company Information
7.25.2 JETEMA Business Overview
7.25.3 JETEMA Anti-aging Drugs Sales, Revenue and Gross Margin (2020-2025)
7.25.4 JETEMA Anti-aging Drugs Products Offered
7.25.5 JETEMA Recent Development
8 Anti-aging Drugs Manufacturing Cost Analysis
8.1 Anti-aging Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Anti-aging Drugs
8.4 Anti-aging Drugs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Anti-aging Drugs Distributors List
9.3 Anti-aging Drugs Customers
10 Anti-aging Drugs Market Dynamics
10.1 Anti-aging Drugs Industry Trends
10.2 Anti-aging Drugs Market Drivers
10.3 Anti-aging Drugs Market Challenges
10.4 Anti-aging Drugs Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Anti-aging Drugs Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Anti-aging Drugs Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Anti-aging Drugs Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Anti-aging Drugs Sales (K Units) by Region (2020-2025)
Table 5. Global Anti-aging Drugs Sales Market Share by Region (2020-2025)
Table 6. Global Anti-aging Drugs Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Anti-aging Drugs Revenue Share by Region (2020-2025)
Table 8. Global Anti-aging Drugs Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Anti-aging Drugs Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Anti-aging Drugs Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Anti-aging Drugs Revenue Share Forecast by Region (2026-2031)
Table 12. Global Anti-aging Drugs Sales by Type (K Units) & (2020-2025)
Table 13. Global Anti-aging Drugs Sales Share by Type (2020-2025)
Table 14. Global Anti-aging Drugs Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Anti-aging Drugs Price by Type (US$/Unit) & (2020-2025)
Table 16. Global Anti-aging Drugs Sales by Type (K Units) & (2026-2031)
Table 17. Global Anti-aging Drugs Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Anti-aging Drugs Price by Type (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Anti-aging Drugs Sales by Application (K Units) & (2020-2025)
Table 21. Global Anti-aging Drugs Sales Share by Application (2020-2025)
Table 22. Global Anti-aging Drugs Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Anti-aging Drugs Price by Application (US$/Unit) & (2020-2025)
Table 24. Global Anti-aging Drugs Sales by Application (K Units) & (2026-2031)
Table 25. Global Anti-aging Drugs Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Anti-aging Drugs Price by Application (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in Anti-aging Drugs Application
Table 28. Global Anti-aging Drugs Sales by Company (K Units) & (2020-2025)
Table 29. Global Anti-aging Drugs Sales Share by Company (2020-2025)
Table 30. Global Anti-aging Drugs Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Anti-aging Drugs Revenue Share by Company (2020-2025)
Table 32. Global Anti-aging Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-aging Drugs as of 2024)
Table 33. Global Market Anti-aging Drugs Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Anti-aging Drugs, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Anti-aging Drugs, Product Type & Application
Table 36. Global Key Manufacturers of Anti-aging Drugs, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Anti-aging Drugs Sales by Company (2020-2025) & (K Units)
Table 39. North America Anti-aging Drugs Sales Market Share by Company (2020-2025)
Table 40. North America Anti-aging Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Anti-aging Drugs Revenue Market Share by Company (2020-2025)
Table 42. North America Anti-aging Drugs Sales by Type (2020-2025) & (K Units)
Table 43. North America Anti-aging Drugs Sales Market Share by Type (2020-2025)
Table 44. North America Anti-aging Drugs Sales by Application (2020-2025) & (K Units)
Table 45. North America Anti-aging Drugs Sales Market Share by Application (2020-2025)
Table 46. Europe Anti-aging Drugs Sales by Company (2020-2025) & (K Units)
Table 47. Europe Anti-aging Drugs Sales Market Share by Company (2020-2025)
Table 48. Europe Anti-aging Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Anti-aging Drugs Revenue Market Share by Company (2020-2025)
Table 50. Europe Anti-aging Drugs Sales by Type (2020-2025) & (K Units)
Table 51. Europe Anti-aging Drugs Sales Market Share by Type (2020-2025)
Table 52. Europe Anti-aging Drugs Sales by Application (2020-2025) & (K Units)
Table 53. Europe Anti-aging Drugs Sales Market Share by Application (2020-2025)
Table 54. China Anti-aging Drugs Sales by Company (2020-2025) & (K Units)
Table 55. China Anti-aging Drugs Sales Market Share by Company (2020-2025)
Table 56. China Anti-aging Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Anti-aging Drugs Revenue Market Share by Company (2020-2025)
Table 58. China Anti-aging Drugs Sales by Type (2020-2025) & (K Units)
Table 59. China Anti-aging Drugs Sales Market Share by Type (2020-2025)
Table 60. China Anti-aging Drugs Sales by Application (2020-2025) & (K Units)
Table 61. China Anti-aging Drugs Sales Market Share by Application (2020-2025)
Table 62. South Korea Anti-aging Drugs Sales by Company (2020-2025) & (K Units)
Table 63. South Korea Anti-aging Drugs Sales Market Share by Company (2020-2025)
Table 64. South Korea Anti-aging Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 65. South Korea Anti-aging Drugs Revenue Market Share by Company (2020-2025)
Table 66. South Korea Anti-aging Drugs Sales by Type (2020-2025) & (K Units)
Table 67. South Korea Anti-aging Drugs Sales Market Share by Type (2020-2025)
Table 68. South Korea Anti-aging Drugs Sales by Application (2020-2025) & (K Units)
Table 69. South Korea Anti-aging Drugs Sales Market Share by Application (2020-2025)
Table 70. Taiwan (China) Anti-aging Drugs Sales by Company (2020-2025) & (K Units)
Table 71. Taiwan (China) Anti-aging Drugs Sales Market Share by Company (2020-2025)
Table 72. Taiwan (China) Anti-aging Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 73. Taiwan (China) Anti-aging Drugs Revenue Market Share by Company (2020-2025)
Table 74. Taiwan (China) Anti-aging Drugs Sales by Type (2020-2025) & (K Units)
Table 75. Taiwan (China) Anti-aging Drugs Sales Market Share by Type (2020-2025)
Table 76. Taiwan (China) Anti-aging Drugs Sales by Application (2020-2025) & (K Units)
Table 77. Taiwan (China) Anti-aging Drugs Sales Market Share by Application (2020-2025)
Table 78. AbbVie Company Information
Table 79. AbbVie Description and Business Overview
Table 80. AbbVie Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. AbbVie Anti-aging Drugs Product
Table 82. AbbVie Recent Development
Table 83. Galderma Company Information
Table 84. Galderma Description and Business Overview
Table 85. Galderma Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Galderma Anti-aging Drugs Product
Table 87. Galderma Recent Development
Table 88. LG Life Sciences Company Information
Table 89. LG Life Sciences Description and Business Overview
Table 90. LG Life Sciences Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. LG Life Sciences Anti-aging Drugs Product
Table 92. LG Life Sciences Recent Development
Table 93. Merz Company Information
Table 94. Merz Description and Business Overview
Table 95. Merz Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Merz Anti-aging Drugs Product
Table 97. Merz Recent Development
Table 98. Medytox Company Information
Table 99. Medytox Description and Business Overview
Table 100. Medytox Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Medytox Anti-aging Drugs Product
Table 102. Medytox Recent Development
Table 103. Hugel Company Information
Table 104. Hugel Description and Business Overview
Table 105. Hugel Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Hugel Anti-aging Drugs Product
Table 107. Hugel Recent Development
Table 108. Croma-Pharma Company Information
Table 109. Croma-Pharma Description and Business Overview
Table 110. Croma-Pharma Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Croma-Pharma Anti-aging Drugs Product
Table 112. Croma-Pharma Recent Development
Table 113. Beijing IMEIK Company Information
Table 114. Beijing IMEIK Description and Business Overview
Table 115. Beijing IMEIK Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Beijing IMEIK Anti-aging Drugs Product
Table 117. Beijing IMEIK Recent Development
Table 118. Bloomage Bio Company Information
Table 119. Bloomage Bio Description and Business Overview
Table 120. Bloomage Bio Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Bloomage Bio Anti-aging Drugs Product
Table 122. Bloomage Bio Recent Development
Table 123. Elravie (Humedix) Company Information
Table 124. Elravie (Humedix) Description and Business Overview
Table 125. Elravie (Humedix) Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 126. Elravie (Humedix) Anti-aging Drugs Product
Table 127. Elravie (Humedix) Recent Development
Table 128. Cleviel (Pharma Research Products) Company Information
Table 129. Cleviel (Pharma Research Products) Description and Business Overview
Table 130. Cleviel (Pharma Research Products) Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 131. Cleviel (Pharma Research Products) Anti-aging Drugs Product
Table 132. Cleviel (Pharma Research Products) Recent Development
Table 133. Haohai Biological Company Information
Table 134. Haohai Biological Description and Business Overview
Table 135. Haohai Biological Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 136. Haohai Biological Anti-aging Drugs Product
Table 137. Haohai Biological Recent Development
Table 138. Teoxane Company Information
Table 139. Teoxane Description and Business Overview
Table 140. Teoxane Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 141. Teoxane Anti-aging Drugs Product
Table 142. Teoxane Recent Development
Table 143. Sinclair Company Information
Table 144. Sinclair Description and Business Overview
Table 145. Sinclair Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 146. Sinclair Anti-aging Drugs Product
Table 147. Sinclair Recent Development
Table 148. Suneva Medical Company Information
Table 149. Suneva Medical Description and Business Overview
Table 150. Suneva Medical Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 151. Suneva Medical Anti-aging Drugs Product
Table 152. Suneva Medical Recent Development
Table 153. CG Bio Company Information
Table 154. CG Bio Description and Business Overview
Table 155. CG Bio Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 156. CG Bio Anti-aging Drugs Product
Table 157. CG Bio Recent Development
Table 158. SciVision Biotech Company Information
Table 159. SciVision Biotech Description and Business Overview
Table 160. SciVision Biotech Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 161. SciVision Biotech Anti-aging Drugs Product
Table 162. SciVision Biotech Recent Development
Table 163. Prollenium Company Information
Table 164. Prollenium Description and Business Overview
Table 165. Prollenium Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 166. Prollenium Anti-aging Drugs Product
Table 167. Prollenium Recent Development
Table 168. Bohus BioTech Company Information
Table 169. Bohus BioTech Description and Business Overview
Table 170. Bohus BioTech Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 171. Bohus BioTech Anti-aging Drugs Product
Table 172. Bohus BioTech Recent Development
Table 173. Caregen Company Information
Table 174. Caregen Description and Business Overview
Table 175. Caregen Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 176. Caregen Anti-aging Drugs Product
Table 177. Caregen Recent Development
Table 178. Ipsen Company Information
Table 179. Ipsen Description and Business Overview
Table 180. Ipsen Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 181. Ipsen Anti-aging Drugs Product
Table 182. Ipsen Recent Development
Table 183. LIBP Company Information
Table 184. LIBP Description and Business Overview
Table 185. LIBP Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 186. LIBP Anti-aging Drugs Product
Table 187. LIBP Recent Development
Table 188. US World Meds Company Information
Table 189. US World Meds Description and Business Overview
Table 190. US World Meds Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 191. US World Meds Anti-aging Drugs Product
Table 192. US World Meds Recent Development
Table 193. Daewoong Company Information
Table 194. Daewoong Description and Business Overview
Table 195. Daewoong Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 196. Daewoong Anti-aging Drugs Product
Table 197. Daewoong Recent Development
Table 198. JETEMA Company Information
Table 199. JETEMA Description and Business Overview
Table 200. JETEMA Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 201. JETEMA Anti-aging Drugs Product
Table 202. JETEMA Recent Development
Table 203. Production Base and Market Concentration Rate of Raw Material
Table 204. Key Suppliers of Raw Materials
Table 205. Anti-aging Drugs Distributors List
Table 206. Anti-aging Drugs Customers List
Table 207. Anti-aging Drugs Market Trends
Table 208. Anti-aging Drugs Market Drivers
Table 209. Anti-aging Drugs Market Challenges
Table 210. Anti-aging Drugs Market Restraints
Table 211. Research Programs/Design for This Report
Table 212. Key Data Information from Secondary Sources
Table 213. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-aging Drugs Product Picture
Figure 2. Global Anti-aging Drugs Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Anti-aging Drugs Sales Market Share by Type in 2024 & 2031
Figure 4. Dermal Fillers Product Picture
Figure 5. Botulinum Toxin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Anti-aging Drugs Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Anti-aging Drugs Sales Market Share by Application in 2024 & 2031
Figure 9. Hospital Examples
Figure 10. Beauty Parlor Examples
Figure 11. Others Examples
Figure 12. Global Anti-aging Drugs Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Anti-aging Drugs Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Anti-aging Drugs Sales (K Units) Growth Rate (2020-2031)
Figure 15. Global Anti-aging Drugs Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 16. Anti-aging Drugs Report Years Considered
Figure 17. Global Market Anti-aging Drugs Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Anti-aging Drugs Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Anti-aging Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Anti-aging Drugs Sales (K Units) Growth Rate (2020-2031)
Figure 21. Europe Anti-aging Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Anti-aging Drugs Sales (K Units) Growth Rate (2020-2031)
Figure 23. China Anti-aging Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Anti-aging Drugs Sales (K Units) Growth Rate (2020-2031)
Figure 25. South Korea Anti-aging Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. South Korea Anti-aging Drugs Sales (K Units) Growth Rate (2020-2031)
Figure 27. Taiwan (China) Anti-aging Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. Taiwan (China) Anti-aging Drugs Sales (K Units) Growth Rate (2020-2031)
Figure 29. Global Anti-aging Drugs Revenue Share by Type (2020-2025)
Figure 30. Global Anti-aging Drugs Sales Share by Type (2026-2031)
Figure 31. Global Anti-aging Drugs Revenue Share by Type (2026-2031)
Figure 32. Global Anti-aging Drugs Revenue Share by Application (2020-2025)
Figure 33. Global Anti-aging Drugs Revenue Growth Rate by Application in 2020 & 2024
Figure 34. Global Anti-aging Drugs Sales Share by Application (2026-2031)
Figure 35. Global Anti-aging Drugs Revenue Share by Application (2026-2031)
Figure 36. Global Anti-aging Drugs Sales Share by Company (2024)
Figure 37. Global Anti-aging Drugs Revenue Share by Company (2024)
Figure 38. Global 5 Largest Anti-aging Drugs Players Market Share by Revenue in Anti-aging Drugs: 2020 & 2024
Figure 39. Anti-aging Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 40. Manufacturing Cost Structure of Anti-aging Drugs
Figure 41. Manufacturing Process Analysis of Anti-aging Drugs
Figure 42. Anti-aging Drugs Industrial Chain
Figure 43. Channels of Distribution (Direct Vs Distribution)
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Table 1. Global Anti-aging Drugs Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Anti-aging Drugs Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Anti-aging Drugs Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Anti-aging Drugs Sales (K Units) by Region (2020-2025)
Table 5. Global Anti-aging Drugs Sales Market Share by Region (2020-2025)
Table 6. Global Anti-aging Drugs Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Anti-aging Drugs Revenue Share by Region (2020-2025)
Table 8. Global Anti-aging Drugs Sales (K Units) Forecast by Region (2026-2031)
Table 9. Global Anti-aging Drugs Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Anti-aging Drugs Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Anti-aging Drugs Revenue Share Forecast by Region (2026-2031)
Table 12. Global Anti-aging Drugs Sales by Type (K Units) & (2020-2025)
Table 13. Global Anti-aging Drugs Sales Share by Type (2020-2025)
Table 14. Global Anti-aging Drugs Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Anti-aging Drugs Price by Type (US$/Unit) & (2020-2025)
Table 16. Global Anti-aging Drugs Sales by Type (K Units) & (2026-2031)
Table 17. Global Anti-aging Drugs Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Anti-aging Drugs Price by Type (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Anti-aging Drugs Sales by Application (K Units) & (2020-2025)
Table 21. Global Anti-aging Drugs Sales Share by Application (2020-2025)
Table 22. Global Anti-aging Drugs Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Anti-aging Drugs Price by Application (US$/Unit) & (2020-2025)
Table 24. Global Anti-aging Drugs Sales by Application (K Units) & (2026-2031)
Table 25. Global Anti-aging Drugs Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Anti-aging Drugs Price by Application (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in Anti-aging Drugs Application
Table 28. Global Anti-aging Drugs Sales by Company (K Units) & (2020-2025)
Table 29. Global Anti-aging Drugs Sales Share by Company (2020-2025)
Table 30. Global Anti-aging Drugs Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Anti-aging Drugs Revenue Share by Company (2020-2025)
Table 32. Global Anti-aging Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-aging Drugs as of 2024)
Table 33. Global Market Anti-aging Drugs Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Anti-aging Drugs, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Anti-aging Drugs, Product Type & Application
Table 36. Global Key Manufacturers of Anti-aging Drugs, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Anti-aging Drugs Sales by Company (2020-2025) & (K Units)
Table 39. North America Anti-aging Drugs Sales Market Share by Company (2020-2025)
Table 40. North America Anti-aging Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Anti-aging Drugs Revenue Market Share by Company (2020-2025)
Table 42. North America Anti-aging Drugs Sales by Type (2020-2025) & (K Units)
Table 43. North America Anti-aging Drugs Sales Market Share by Type (2020-2025)
Table 44. North America Anti-aging Drugs Sales by Application (2020-2025) & (K Units)
Table 45. North America Anti-aging Drugs Sales Market Share by Application (2020-2025)
Table 46. Europe Anti-aging Drugs Sales by Company (2020-2025) & (K Units)
Table 47. Europe Anti-aging Drugs Sales Market Share by Company (2020-2025)
Table 48. Europe Anti-aging Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Anti-aging Drugs Revenue Market Share by Company (2020-2025)
Table 50. Europe Anti-aging Drugs Sales by Type (2020-2025) & (K Units)
Table 51. Europe Anti-aging Drugs Sales Market Share by Type (2020-2025)
Table 52. Europe Anti-aging Drugs Sales by Application (2020-2025) & (K Units)
Table 53. Europe Anti-aging Drugs Sales Market Share by Application (2020-2025)
Table 54. China Anti-aging Drugs Sales by Company (2020-2025) & (K Units)
Table 55. China Anti-aging Drugs Sales Market Share by Company (2020-2025)
Table 56. China Anti-aging Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Anti-aging Drugs Revenue Market Share by Company (2020-2025)
Table 58. China Anti-aging Drugs Sales by Type (2020-2025) & (K Units)
Table 59. China Anti-aging Drugs Sales Market Share by Type (2020-2025)
Table 60. China Anti-aging Drugs Sales by Application (2020-2025) & (K Units)
Table 61. China Anti-aging Drugs Sales Market Share by Application (2020-2025)
Table 62. South Korea Anti-aging Drugs Sales by Company (2020-2025) & (K Units)
Table 63. South Korea Anti-aging Drugs Sales Market Share by Company (2020-2025)
Table 64. South Korea Anti-aging Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 65. South Korea Anti-aging Drugs Revenue Market Share by Company (2020-2025)
Table 66. South Korea Anti-aging Drugs Sales by Type (2020-2025) & (K Units)
Table 67. South Korea Anti-aging Drugs Sales Market Share by Type (2020-2025)
Table 68. South Korea Anti-aging Drugs Sales by Application (2020-2025) & (K Units)
Table 69. South Korea Anti-aging Drugs Sales Market Share by Application (2020-2025)
Table 70. Taiwan (China) Anti-aging Drugs Sales by Company (2020-2025) & (K Units)
Table 71. Taiwan (China) Anti-aging Drugs Sales Market Share by Company (2020-2025)
Table 72. Taiwan (China) Anti-aging Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 73. Taiwan (China) Anti-aging Drugs Revenue Market Share by Company (2020-2025)
Table 74. Taiwan (China) Anti-aging Drugs Sales by Type (2020-2025) & (K Units)
Table 75. Taiwan (China) Anti-aging Drugs Sales Market Share by Type (2020-2025)
Table 76. Taiwan (China) Anti-aging Drugs Sales by Application (2020-2025) & (K Units)
Table 77. Taiwan (China) Anti-aging Drugs Sales Market Share by Application (2020-2025)
Table 78. AbbVie Company Information
Table 79. AbbVie Description and Business Overview
Table 80. AbbVie Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. AbbVie Anti-aging Drugs Product
Table 82. AbbVie Recent Development
Table 83. Galderma Company Information
Table 84. Galderma Description and Business Overview
Table 85. Galderma Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Galderma Anti-aging Drugs Product
Table 87. Galderma Recent Development
Table 88. LG Life Sciences Company Information
Table 89. LG Life Sciences Description and Business Overview
Table 90. LG Life Sciences Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. LG Life Sciences Anti-aging Drugs Product
Table 92. LG Life Sciences Recent Development
Table 93. Merz Company Information
Table 94. Merz Description and Business Overview
Table 95. Merz Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Merz Anti-aging Drugs Product
Table 97. Merz Recent Development
Table 98. Medytox Company Information
Table 99. Medytox Description and Business Overview
Table 100. Medytox Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Medytox Anti-aging Drugs Product
Table 102. Medytox Recent Development
Table 103. Hugel Company Information
Table 104. Hugel Description and Business Overview
Table 105. Hugel Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Hugel Anti-aging Drugs Product
Table 107. Hugel Recent Development
Table 108. Croma-Pharma Company Information
Table 109. Croma-Pharma Description and Business Overview
Table 110. Croma-Pharma Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Croma-Pharma Anti-aging Drugs Product
Table 112. Croma-Pharma Recent Development
Table 113. Beijing IMEIK Company Information
Table 114. Beijing IMEIK Description and Business Overview
Table 115. Beijing IMEIK Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Beijing IMEIK Anti-aging Drugs Product
Table 117. Beijing IMEIK Recent Development
Table 118. Bloomage Bio Company Information
Table 119. Bloomage Bio Description and Business Overview
Table 120. Bloomage Bio Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Bloomage Bio Anti-aging Drugs Product
Table 122. Bloomage Bio Recent Development
Table 123. Elravie (Humedix) Company Information
Table 124. Elravie (Humedix) Description and Business Overview
Table 125. Elravie (Humedix) Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 126. Elravie (Humedix) Anti-aging Drugs Product
Table 127. Elravie (Humedix) Recent Development
Table 128. Cleviel (Pharma Research Products) Company Information
Table 129. Cleviel (Pharma Research Products) Description and Business Overview
Table 130. Cleviel (Pharma Research Products) Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 131. Cleviel (Pharma Research Products) Anti-aging Drugs Product
Table 132. Cleviel (Pharma Research Products) Recent Development
Table 133. Haohai Biological Company Information
Table 134. Haohai Biological Description and Business Overview
Table 135. Haohai Biological Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 136. Haohai Biological Anti-aging Drugs Product
Table 137. Haohai Biological Recent Development
Table 138. Teoxane Company Information
Table 139. Teoxane Description and Business Overview
Table 140. Teoxane Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 141. Teoxane Anti-aging Drugs Product
Table 142. Teoxane Recent Development
Table 143. Sinclair Company Information
Table 144. Sinclair Description and Business Overview
Table 145. Sinclair Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 146. Sinclair Anti-aging Drugs Product
Table 147. Sinclair Recent Development
Table 148. Suneva Medical Company Information
Table 149. Suneva Medical Description and Business Overview
Table 150. Suneva Medical Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 151. Suneva Medical Anti-aging Drugs Product
Table 152. Suneva Medical Recent Development
Table 153. CG Bio Company Information
Table 154. CG Bio Description and Business Overview
Table 155. CG Bio Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 156. CG Bio Anti-aging Drugs Product
Table 157. CG Bio Recent Development
Table 158. SciVision Biotech Company Information
Table 159. SciVision Biotech Description and Business Overview
Table 160. SciVision Biotech Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 161. SciVision Biotech Anti-aging Drugs Product
Table 162. SciVision Biotech Recent Development
Table 163. Prollenium Company Information
Table 164. Prollenium Description and Business Overview
Table 165. Prollenium Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 166. Prollenium Anti-aging Drugs Product
Table 167. Prollenium Recent Development
Table 168. Bohus BioTech Company Information
Table 169. Bohus BioTech Description and Business Overview
Table 170. Bohus BioTech Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 171. Bohus BioTech Anti-aging Drugs Product
Table 172. Bohus BioTech Recent Development
Table 173. Caregen Company Information
Table 174. Caregen Description and Business Overview
Table 175. Caregen Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 176. Caregen Anti-aging Drugs Product
Table 177. Caregen Recent Development
Table 178. Ipsen Company Information
Table 179. Ipsen Description and Business Overview
Table 180. Ipsen Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 181. Ipsen Anti-aging Drugs Product
Table 182. Ipsen Recent Development
Table 183. LIBP Company Information
Table 184. LIBP Description and Business Overview
Table 185. LIBP Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 186. LIBP Anti-aging Drugs Product
Table 187. LIBP Recent Development
Table 188. US World Meds Company Information
Table 189. US World Meds Description and Business Overview
Table 190. US World Meds Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 191. US World Meds Anti-aging Drugs Product
Table 192. US World Meds Recent Development
Table 193. Daewoong Company Information
Table 194. Daewoong Description and Business Overview
Table 195. Daewoong Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 196. Daewoong Anti-aging Drugs Product
Table 197. Daewoong Recent Development
Table 198. JETEMA Company Information
Table 199. JETEMA Description and Business Overview
Table 200. JETEMA Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 201. JETEMA Anti-aging Drugs Product
Table 202. JETEMA Recent Development
Table 203. Production Base and Market Concentration Rate of Raw Material
Table 204. Key Suppliers of Raw Materials
Table 205. Anti-aging Drugs Distributors List
Table 206. Anti-aging Drugs Customers List
Table 207. Anti-aging Drugs Market Trends
Table 208. Anti-aging Drugs Market Drivers
Table 209. Anti-aging Drugs Market Challenges
Table 210. Anti-aging Drugs Market Restraints
Table 211. Research Programs/Design for This Report
Table 212. Key Data Information from Secondary Sources
Table 213. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-aging Drugs Product Picture
Figure 2. Global Anti-aging Drugs Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Anti-aging Drugs Sales Market Share by Type in 2024 & 2031
Figure 4. Dermal Fillers Product Picture
Figure 5. Botulinum Toxin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Anti-aging Drugs Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Anti-aging Drugs Sales Market Share by Application in 2024 & 2031
Figure 9. Hospital Examples
Figure 10. Beauty Parlor Examples
Figure 11. Others Examples
Figure 12. Global Anti-aging Drugs Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Anti-aging Drugs Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Anti-aging Drugs Sales (K Units) Growth Rate (2020-2031)
Figure 15. Global Anti-aging Drugs Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 16. Anti-aging Drugs Report Years Considered
Figure 17. Global Market Anti-aging Drugs Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Anti-aging Drugs Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Anti-aging Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Anti-aging Drugs Sales (K Units) Growth Rate (2020-2031)
Figure 21. Europe Anti-aging Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Anti-aging Drugs Sales (K Units) Growth Rate (2020-2031)
Figure 23. China Anti-aging Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Anti-aging Drugs Sales (K Units) Growth Rate (2020-2031)
Figure 25. South Korea Anti-aging Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. South Korea Anti-aging Drugs Sales (K Units) Growth Rate (2020-2031)
Figure 27. Taiwan (China) Anti-aging Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. Taiwan (China) Anti-aging Drugs Sales (K Units) Growth Rate (2020-2031)
Figure 29. Global Anti-aging Drugs Revenue Share by Type (2020-2025)
Figure 30. Global Anti-aging Drugs Sales Share by Type (2026-2031)
Figure 31. Global Anti-aging Drugs Revenue Share by Type (2026-2031)
Figure 32. Global Anti-aging Drugs Revenue Share by Application (2020-2025)
Figure 33. Global Anti-aging Drugs Revenue Growth Rate by Application in 2020 & 2024
Figure 34. Global Anti-aging Drugs Sales Share by Application (2026-2031)
Figure 35. Global Anti-aging Drugs Revenue Share by Application (2026-2031)
Figure 36. Global Anti-aging Drugs Sales Share by Company (2024)
Figure 37. Global Anti-aging Drugs Revenue Share by Company (2024)
Figure 38. Global 5 Largest Anti-aging Drugs Players Market Share by Revenue in Anti-aging Drugs: 2020 & 2024
Figure 39. Anti-aging Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 40. Manufacturing Cost Structure of Anti-aging Drugs
Figure 41. Manufacturing Process Analysis of Anti-aging Drugs
Figure 42. Anti-aging Drugs Industrial Chain
Figure 43. Channels of Distribution (Direct Vs Distribution)
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232